- Investing Ideas
- U.K. Pharmaceuticals & Biotech High Insider Buying
U.K. Pharmaceuticals & Biotech High Insider Buying
Results
8
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
8 companies
GSK
Market Cap: UK£76.4b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK
UK£19.15
7D
2.8%
1Y
34.3%
Hikma Pharmaceuticals
Market Cap: UK£3.1b
Develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products.
HIK
UK£14.59
7D
1.3%
1Y
-29.7%
Oxford Nanopore Technologies
Market Cap: UK£1.3b
Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA.
ONT
UK£1.29
7D
7.5%
1Y
2.6%
Animalcare Group
Market Cap: UK£228.9m
Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.
ANCR
UK£3.32
7D
-0.2%
1Y
30.5%
Diaceutics
Market Cap: UK£141.0m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.67
7D
-1.5%
1Y
19.8%
Bioventix
Market Cap: UK£87.5m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£16.75
7D
-1.5%
1Y
-42.2%
Faron Pharmaceuticals Oy
Market Cap: UK£82.8m
Operates as a clinical stage drug discovery and development company.
FARN
UK£0.41
7D
-4.6%
1Y
-82.3%
ValiRx
Market Cap: UK£1.5m
A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.
VAL
UK£0.0019
7D
-2.5%
1Y
-64.5%